XML 30 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Financial Instruments
3 Months Ended
Mar. 31, 2019
Investments, All Other Investments [Abstract]  
Financial Instruments
FINANCIAL INSTRUMENTS
Fair Value
Accounting guidance on fair value measurements specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs create the following fair value hierarchy:
Level 1 — Quoted prices for identical instruments in active markets.
Level 2 — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.
Level 3 — Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. The Company determines the fair value of structured liabilities (where performance is linked to structured interest rates, inflation or currency risks) using the London Interbank Offer Rate ("LIBOR") swap curve and forward interest and exchange rates at period end. Such instruments are classified as Level 2 based on the observability of significant inputs to the model. The Company does not have any instruments classified as Level 3, other than those included in pension asset trusts as discussed in Note 16 of our 2018 Form 10-K.
These valuations take into consideration the Company's credit risk and its counterparties’ credit risk. The estimated change in the fair value of these instruments due to such changes in its own credit risk (or instrument-specific credit risk) was immaterial as of March 31, 2019.
The carrying values and the estimated fair values of financial instruments at March 31, 2019 and December 31, 2018 consisted of the following: 
 
March 31, 2019
 
December 31, 2018
(DOLLARS IN THOUSANDS)
Carrying Value
 
Fair Value
 
Carrying Value
 
Fair Value
LEVEL 1
 
 
 
 
 
 
 
Cash and cash equivalents(1)
$
483,504

 
$
483,504

 
$
634,897

 
$
634,897

LEVEL 2
 
 
 
 
 
 
 
Credit facilities and bank overdrafts(2)
8,231

 
8,231

 
4,695

 
4,695

Derivatives(3)
 
 
 
 
 
 
 
Derivative assets

 
21,296

 

 
7,229

Derivative liabilities

 
3,220

 

 
6,907

Long-term debt:(3)
 
 
 
 
 
 
 
2020 Notes
298,743

 
299,291

 
298,499

 
300,356

2021 Euro Notes
334,486

 
340,073

 
337,704

 
341,094

2023 Notes
298,774

 
298,642

 
298,698

 
293,017

2024 Euro Notes
558,869

 
596,056

 
564,034

 
584,129

2026 Euro Notes
891,757

 
934,385

 
899,886

 
909,439

2028 Notes
396,460

 
414,879

 
396,377

 
401,231

2047 Notes
493,256

 
472,958

 
493,151

 
446,725

2048 Notes
785,838

 
828,682

 
785,788

 
783,925

Term Loan(2)
324,295

 
325,000

 
349,163

 
350,000

Amortizing Notes(4)
114,667

 
117,579

 
125,007

 
127,879

_______________________
(1)
The carrying amount of cash and cash equivalents approximates fair value due to the short maturity of those instruments.
(2)
The carrying amount approximates fair value as the interest rate is reset frequently based on current market rates as well as the short maturity of those instruments.
(3)
The fair value of the Company's long-term debt was calculated using discounted cash flows applying current interest rates and current credit spreads based on its own credit risk.
(4)
The fair value of the Amortizing Notes of the TEUs is based on the most recently quoted price for the outstanding securities, adjusted for any known significant deviation in value. The estimated fair value of these long-term obligations is not necessarily indicative of the amount that would be realized in a current market exchange.
Derivatives
The Company periodically enters into foreign currency forward contracts with the objective of reducing exposure to cash flow volatility associated with its intercompany loans, foreign currency receivables and payables, and anticipated purchases of certain raw materials used in operations. These contracts generally involve the exchange of one currency for a second currency at a future date, have maturities not exceeding twelve months and are with counterparties which are major international financial institutions.
In prior years, the Company entered into several forward currency contracts which qualified as cash flow hedges. The objective of these hedges is to protect against the currency risk associated with forecasted U.S. dollar ("USD") denominated raw material purchases made by Euro ("EUR") functional currency entities which result from changes in the EUR/USD exchange rate. The change in the value of the cash flow hedges is recorded in OCI as a component of gains/(losses) on derivatives qualifying as hedges in the accompanying Consolidated Statement of Income and Comprehensive Income. Realized gains/(losses) in AOCI related to cash flow hedges of raw material purchases are recognized as a component of Cost of goods sold in the accompanying Consolidated Statement of Income and Comprehensive Income in the same period as the related costs are recognized.
In prior years, the Company designated the 2021 Euro Notes, 2024 Euro Notes and 2026 Euro Notes as a hedge of a portion of its net investment in Euro functional currency subsidiaries. Accordingly, the change in the value of the debt that is attributable to foreign exchange movements is recorded in OCI as a component of Foreign currency translation adjustments in the accompanying Consolidated Statement of Income and Comprehensive Income.
In prior years, the Company entered into certain cross currency swaps which qualified as net investment hedges in order to mitigate a portion of its net European investments from foreign currency risk. Changes in fair value related to cross currency swaps are recorded in OCI as a component of the Foreign currency translation adjustments.
In prior years, the Company entered into interest rate swap agreements to hedge the anticipated issuance of fixed-rate debt, which are designated as cash flow hedges. The amount of gains and losses realized upon termination of these agreements is amortized over the life of the corresponding debt issuance.
The following table shows the notional amount of the Company’s derivative instruments outstanding as of March 31, 2019 and December 31, 2018: 
(DOLLARS IN THOUSANDS)
March 31, 2019
 
December 31, 2018
Foreign currency contracts
$
460,758

 
$
585,581

Cross currency swaps
600,000

 
600,000


The following tables show the Company’s derivative instruments measured at fair value (Level 2 of the fair value hierarchy), as reflected in the Consolidated Balance Sheet as of March 31, 2019 and December 31, 2018: 
 
March 31, 2019
(DOLLARS IN THOUSANDS)
Fair Value of
Derivatives
Designated as
Hedging
Instruments
 
Fair Value of
Derivatives Not
Designated as
Hedging
Instruments
 
Total Fair Value
Derivative assets (a)
 
 
 
 
 
Foreign currency contracts
$
3,926

 
$
1,001

 
$
4,927

Cross currency swaps
16,369

 

 
16,369

 
$
20,295

 
$
1,001

 
$
21,296

Derivative liabilities (b)
 
 
 
 
 
Foreign currency contract
$
90

 
$
3,130

 
$
3,220

 
December 31, 2018
(DOLLARS IN THOUSANDS)
Fair Value of
Derivatives
Designated as
Hedging
Instruments
 
Fair Value of
Derivatives Not
Designated as
Hedging
Instruments
 
Total Fair Value
Derivative assets (a)
 
 
 
 
 
Foreign currency contracts
$
4,122

 
$
2,020

 
$
6,142

Cross currency swaps
1,087

 

 
1,087

 
$
5,209

 
$
2,020

 
$
7,229

Derivative liabilities (b)
 
 
 
 
 
Foreign currency contracts
$
205

 
$
6,702

 
$
6,907

 _______________________
(a)
Derivative assets are recorded to Prepaid expenses and Other assets in the Consolidated Balance Sheet.
(b)
Derivative liabilities are recorded as Other current liabilities in the Consolidated Balance Sheet.
The following table shows the effect of the Company’s derivative instruments which were not designated as hedging instruments in the Consolidated Statement of Income and Comprehensive Income for the three months ended March 31, 2019 and 2018 (in thousands): 
 
Amount of Gain (Loss)
 
Location of Gain (Loss) Recognized in Income on Derivative
(DOLLARS IN THOUSANDS)
Three Months Ended March 31,
 
2019
 
2018
 
Foreign currency contracts
$
926

 
$
(3,615
)
 
Other (income) expense, net

Most of these net gains (losses) offset any recognized gains (losses) arising from the revaluation of the related intercompany loans during the same respective periods.
The following table shows the effect of the Company’s derivative and non-derivative instruments designated as cash flow and net investment hedging instruments, net of tax, in the Consolidated Statement of Income and Comprehensive Income for the three months ended March 31, 2019 and 2018 (in thousands): 
 
Amount of Gain (Loss) 
Recognized in OCI on
Derivative
 
Location of Gain (Loss) Reclassified from
AOCI into Income
 
Amount of Gain (Loss) 
Reclassified from
Accumulated OCI into
Income
 
Three Months Ended March 31,
 
 
Three Months Ended March 31,
 
2019
 
2018
 
 
2019
 
2018
Derivatives in Cash Flow Hedging Relationships:
 
 
 
 
 
 
 
 
 
Foreign currency contracts
$
(312
)
 
$
(743
)
 
Cost of goods sold
 
$
2,372

 
$
(2,193
)
Interest rate swaps (1)
216

 
216

 
Interest expense
 
(216
)
 
(216
)
Derivatives in Net Investment Hedging Relationships:
 
 
 
 
 
 
 
 
 
Foreign currency contracts

 
(696
)
 
N/A
 

 

Cross currency swaps
10,667

 

 
N/A
 

 

Non-Derivatives in Net Investment Hedging Relationships:
 
 
 
 
 
 
 
 
 
2024 Euro Notes
4,206

 
(15,977
)
 
N/A
 

 

2021 Euro Notes & 2026 Euro Notes
9,253

 

 
N/A
 

 

Total
$
24,030

 
$
(17,200
)
 
 
 
$
2,156

 
$
(2,409
)
 _______________________
(1)
Interest rate swaps were entered into as pre-issuance hedges for bond offerings.
The ineffective portion of the above noted cash flow hedges were not material during the three months ended March 31, 2018.
The Company expects that approximately $6.2 million (net of tax) of derivative gain included in AOCI at March 31, 2019, based on current market rates, will be reclassified into earnings within the next 12 months. The majority of this amount will vary due to fluctuations in foreign currency exchange rates.